Research Alliance III completed key financing steps around its initial public offering. The company executed an Underwriting Agreement with Leerink Partners for a $75 million IPO of 7,500,000 Class A shares at $10.00 each, and concurrently closed a $2.75 million sponsor private placement of 275,000 shares. It also established a trust account under an Investment Management Trust Agreement with Continental Stock Transfer & Trust, depositing $75 million, including the underwriter’s deferred commission, to protect funds for public shareholders until a business combination or liquidation. These actions provide capital and a safeguarded structure to pursue the company’s acquisition strategy.
Agreement 1: Research Alliance III Executes Underwriting Agreement for $75 Million IPO With Leerink Partners
- Agreement type: Underwriting Agreement for initial public offering
- Counterparty: Leerink Partners
- Signed / Effective: May 19 2026 / May 19 2026
- Duration / Termination: Through IPO closing
- Reason: Complete IPO and raise capital
Agreement 2: Research Alliance III Raises $2.75 Million in Sponsor Private Placement of 275,000 Shares
- Agreement type: Private Placement Shares Purchase Agreement
- Counterparty: Research Alliance Holdings III
- Signed / Effective: May 19 2026 / May 21 2026
- Duration / Termination: At will
- Reason: Provide additional capital and align sponsor with shareholders
Agreement 3: Research Alliance III Establishes IPO Trust Account With Continental Stock Transfer & Trust
- Agreement type: Investment Management Trust Agreement
- Counterparty: Continental Stock Transfer & Trust
- Signed / Effective: May 19 2026 / May 19 2026
- Duration / Termination: Until business combination or liquidation
- Reason: Safeguard IPO proceeds for shareholders
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.